HLS Therapeutics, Inc. (HLS.TO)
3.69
-0.06
(-1.60%)
CAD |
TSX |
Aug 24, 16:00
HLS Therapeutics Net Income (Quarterly) : -1.412M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.412M |
| March 31, 2026 | -3.151M |
| December 31, 2025 | -1.862M |
| September 30, 2025 | -5.396M |
| June 30, 2025 | -3.796M |
| March 31, 2025 | -6.365M |
| December 31, 2024 | -4.228M |
| September 30, 2024 | -6.607M |
| June 30, 2024 | -7.774M |
| March 31, 2024 | -8.234M |
| December 31, 2023 | -7.356M |
| September 30, 2023 | -9.256M |
| June 30, 2023 | -12.67M |
| March 31, 2023 | -7.834M |
| December 31, 2022 | -8.728M |
| September 30, 2022 | -5.760M |
| June 30, 2022 | -11.67M |
| March 31, 2022 | -4.580M |
| December 31, 2021 | -5.279M |
| September 30, 2021 | -2.494M |
| June 30, 2021 | -2.698M |
| March 31, 2021 | -6.018M |
| December 31, 2020 | -9.484M |
| September 30, 2020 | -2.309M |
| June 30, 2020 | -8.969M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2071M |
| December 31, 2019 | -16.13M |
| September 30, 2019 | -2.639M |
| June 30, 2019 | -2.182M |
| March 31, 2019 | -4.923M |
| December 31, 2018 | 0.4873M |
| September 30, 2018 | -25.80M |
| June 30, 2018 | -0.7269M |
| March 31, 2018 | -6.167M |
| September 30, 2017 | -2.396M |
| June 30, 2017 | -0.9867M |
| March 31, 2017 | -4.013M |
| December 31, 2016 | -0.412M |
| September 30, 2016 | -0.129M |
| June 30, 2016 | -0.30M |
| March 31, 2016 | -0.335M |
| December 31, 2015 | -0.354M |
| September 30, 2015 | -0.331M |
| June 30, 2015 | -0.076M |
| March 31, 2015 | -1.643M |
| December 31, 2014 | 6.306M |
| September 30, 2014 | 3.726M |
| June 30, 2014 | 1.571M |
| March 31, 2014 | 3.16M |
| December 31, 2013 | 3.483M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | 359.94M |
| Cipher Pharmaceuticals, Inc. | 5.556M |
| BioSyent, Inc. | 2.849M |
| Revive Therapeutics Ltd. | -0.5065M |
| Knight Therapeutics, Inc. | -3.361M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 20.31M |
| Total Expenses (Quarterly) | 21.73M |
| EPS Diluted (Quarterly) | -0.0451 |
| Enterprise Value | 155.36M |
| Gross Profit Margin (Quarterly) | 42.90% |
| Profit Margin (Quarterly) | -6.95% |
| Earnings Yield | -10.22% |
| Normalized Earnings Yield | -9.268 |